Trexquant Investment’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-71,107
| Closed | -$610K | – | 1510 |
|
|
2025
Q1 | $610K | Sell |
71,107
-367
| -0.5% | -$3.15K | 0.01% | 1233 |
|
|
2024
Q4 | $768K | Buy |
71,474
+15,109
| +27% | +$162K | 0.01% | 1179 |
|
|
2024
Q3 | $320K | Buy |
+56,365
| New | +$320K | ﹤0.01% | 1338 |
|
|
2024
Q2 | – | Sell |
-83,185
| Closed | -$423K | – | 1510 |
|
|
2024
Q1 | $423K | Buy |
83,185
+25,530
| +44% | +$130K | 0.01% | 1199 |
|
|
2023
Q4 | $537K | Buy |
+57,655
| New | +$537K | 0.01% | 1058 |
|
|
2023
Q2 | – | Sell |
-59,695
| Closed | -$512K | – | 1430 |
|
|
2023
Q1 | $512K | Sell |
59,695
-123,418
| -67% | -$1.06M | 0.01% | 988 |
|
|
2022
Q4 | $1.7M | Buy |
183,113
+166,363
| +993% | +$1.54M | 0.05% | 468 |
|
|
2022
Q3 | $173K | Sell |
16,750
-13,271
| -44% | -$137K | 0.01% | 1222 |
|
|
2022
Q2 | $301K | Buy |
+30,021
| New | +$301K | 0.01% | 1114 |
|
|
2022
Q1 | – | Sell |
-13,601
| Closed | -$236K | – | 1345 |
|
|
2021
Q4 | $236K | Sell |
13,601
-1,654
| -11% | -$28.7K | 0.01% | 1050 |
|
|
2021
Q3 | $274K | Buy |
+15,255
| New | +$274K | 0.02% | 782 |
|